Skip to Content

Rapacuronium Pregnancy and Breastfeeding Warnings

Rapacuronium is also known as: Raplon

Rapacuronium Pregnancy Warnings

Rapacuronium has been assigned to pregnancy category C by the FDA. Animal studies have revealed evidence of fetotoxicity and increased resorption. There are no controlled data in human pregnancy. It has been reported that following a single maternal dose, there was a passage of low levels of rapacuronium across the placenta and slow elimination. Rapacuronium is only recommended for use during pregnancy if the potential benefit to the patient outweighs the potential risk to the fetus. This warning does not apply to the use of rapacuronium during Cesarean section. However, monitoring of the infant is recommended after delivery.

See references

Rapacuronium Breastfeeding Warnings

There are no data on the excretion of rapacuronium into human milk. Because many drugs are excreted into human milk, caution is recommended if rapacuronium is to be used in a nursing mother.

See references

References for pregnancy information

  1. "Product Information. Raplon (rapacuronium)" Organon, West Orange, NJ.

References for breastfeeding information

  1. "Product Information. Raplon (rapacuronium)" Organon, West Orange, NJ.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.